Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Audrey Thomson

BIT225 Effective Against Established SARS-CoV-2 in Animals

2 May 2022 by Audrey Thomson

BIT225 Effective Against Established SARS-CoV-2 in Animals

Categories 2022, ASX Announcements

Report on Activities for the Quarter ended 31 March 2022

26 April 2022 by Audrey Thomson

Report on Activities for the Quarter Ended 31 March 2022

Categories 2022, ASX Announcements

Quarterly Report 31 March 2022

26 April 2022 by Audrey Thomson

Quarterly Report 31 March 2022

Categories 2022, ASX Announcements, Quarterly Reports

R&D Tax Incentive

5 April 2022 by Audrey Thomson

R&D Tax Incentive

Categories 2022, ASX Announcements

Confirmation of BIT225 Effectiveness Against COVID-19 in Animals

17 March 2022 by Audrey Thomson

Confirmation of BIT225 Effectiveness Against COVID-19 in Animals

Categories 2022, ASX Announcements

Half-year Report 31 December 2021

23 February 2022 by Audrey Thomson

Half-year Report 31 December 2021

Categories 2022, ASX Announcements, Half-year reports

Report on Activities for the Quarter ended 31 December 2021

31 January 202228 January 2022 by Audrey Thomson

Report on Activities for the Quarter Ended 31 December 2021

Categories 2022, ASX Announcements

Quarterly Report 31 December 2021

31 January 202228 January 2022 by Audrey Thomson

Quarterly Report 31 December 2021

Categories 2022, ASX Announcements, Quarterly Reports

Update on Biotron’s HIV-1 and COVID-19 Programs

16 December 2021 by Audrey Thomson

Update on Biotron’s HIV-1 and COVID-19 Programs

Categories 2021, ASX Announcements

Presentation to Investors

25 November 2021 by Audrey Thomson

Presentation to Investors

Categories Corporate Presentations
Post navigation
Older posts
Page1 Page2 … Page27 Next →
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 2 May 2022        Legal Notices and Privacy